Amelioration of ulcerative colitis via inflammatory regulation by macrophage-biomimetic nanomedicine
Open accessThe DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
Abstract
This macrophage-biomimetic nanomedicine leverages the inflammatory tropism and inflammatory cytokine sequestration effects of macrophage membrane for targeted delivery and local inflammation suppression, the ROS-responsiveness of β-cyclodextrin-based matrix for specific payload release, and the macrophage-polarizing effect of rosiglitazone for inflammatory regulation, thereby exhibiting considerable therapeutic efficacy against UC in mice. This study offers important new insights on the design and development of biomimetic nanomaterials for inflammation regulations.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Principles of nanoparticle design for overcoming biological barriers to drug delivery
Blanco, E., Shen, H., & Ferrari, M. (2015) · Nature Biotechnology · doi:10.1038/nbt.3330 · Cited by 7,002 · cited 1×
“5 in all formulations mainly accumulated in the liver due to the liver’s filtration effects [49].”
BackgroundAlternative activation of macrophages: mechanism and functions
Gordon, S., & Martinez, F. O. (2010) · Immunity · doi:10.1016/j.immuni.2010.05.007 · Cited by 4,197 · cited 1×
“M1 macrophages produce pro-inflammatory cytokines and ROS, whereas M2 macrophages secret anti-inflammatory cytokines, accelerate inflammation resolution and promote tissue repair [42, 43], thus M2 macrophage was previously leveraged for UC therapy [22].”
BackgroundLehmann, J. M., Moore, L. B., Smith-Oliver, T. A., Wilkison, W. O., Willson, T. M., & Kliewer, S. A. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.22.12953 · Cited by 3,625
Ford Alexander, C., Paul, M., Hanauer Steven, B., 谭蓓, & Dong, W. Z. (2001) · Cited by 3,021
Erythrocyte membrane-camouflaged polymeric nanoparticles as a biomimetic delivery platform
Hu, C.-M. J., Zhang, L., Aryal, S., Cheung, C., Fang, R. H., & Zhang, L. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1106634108 · Cited by 2,433 · cited 1×
“For instance, poly(lactic-co-glycolic acid) (PLGA) NPs coated with red blood cell (RBC) membrane developed by Zhang et al not only prolonged the systemic circulation of the NPs, but also absorbed pore-forming toxins in bacterial infection, thus protected RBC and prevented hemolysis [15, 16].”
BackgroundIntestinal homeostasis and its breakdown in inflammatory bowel disease
Maloy, K. J., & Powrie, F. (2011) · Nature · doi:10.1038/nature10208 · Cited by 1,870 · cited 1×
“During the development of colitis, proinflammatory cytokines are generally over-expressed and participate in the pathogenesis of the inflammatory tissues [51].”
BackgroundIRF5 promotes inflammatory macrophage polarization and TH1-TH17 responses
Krausgruber, T., Blazek, K., Smallie, T., Alzabin, S., Lockstone, H., Sahgal, N., Hussell, T., Feldmann, M., & Udalova, I. A. (2011) · Nature Immunology · doi:10.1038/ni.1990 · Cited by 1,306 · cited 1×
“As a part of immunological response, a large number of macrophages are recruited and accumulate in the ulcerative colon, resulting in sustained inflammation [40, 41].”
BackgroundParodi, A., Quattrocchi, N., van de Ven, A. L., Chiappini, C., Evangelopoulos, M., Martinez, J. O., Brown, B. S., Khaled, S. Z., Yazdi, I. K., Enzo, M. V., et al. (2013) · Nature Nanotechnology · doi:10.1038/nnano.2012.212 · Cited by 1,168 · cited 1×
“9 times attributed to the homing effects and the reduced reticuloendothelial system (RES) clearance of macrophage-biomimetic NPs [50].”
BackgroundThe burden of inflammatory bowel disease in Europe
Burisch, J., Jess, T., Martinato, M., & Lakatos, P. L. (2013) · Journal of Crohn's and Colitis · doi:10.1016/j.crohns.2013.01.010 · Cited by 961 · cited 1×
“As the etiology is not clearly elucidated, the clinical treatments by pharmacotherapy nowadays are not very satisfactory, reflected by a high relapse rate and elevated risk of carcinogenesis [3, 4], mainly due to the poor specificity and inadequate suppression of Ivyspring”
BackgroundBone Marrow-Derived Macrophages (BMM): Isolation and Applications
Weischenfeldt, J., & Porse, B. (2008) · Cold Spring Harbor Protocols · doi:10.1101/pdb.prot5080 · Cited by 955 · cited 1×
“Bone marrow derived macrophages (BMDM) were isolated and differentiated according to a previously reported method [32].”
MethodA biomimetic nanosponge that absorbs pore-forming toxins
Hu, C.-M. J., Fang, R. H., Copp, J., Luk, B. T., & Zhang, L. (2013) · Nature Nanotechnology · doi:10.1038/nnano.2013.54 · Cited by 751 · cited 1×
“For instance, poly(lactic-co-glycolic acid) (PLGA) NPs coated with red blood cell (RBC) membrane developed by Zhang et al not only prolonged the systemic circulation of the NPs, but also absorbed pore-forming toxins in bacterial infection, thus protected RBC and prevented hemolysis [15, 16].”
BackgroundRole of cytokines in inflammatory bowel disease
Sanchez-Muñoz, F., Dominguez-Lopez, A., & Yamamoto-Furusho, J. K. (2008) · World Journal of Gastroenterology · doi:10.3748/wjg.14.4280 · Cited by 699 · cited 1×
“As shown (Figure S7A), the viability of Caco-2 cells was decreased significantly when co-cultured with LPS polarized macrophages that could secrete proinflammatory cytokines and cause damage to Caco-2 cells [48].”
BackgroundMacrophage phenotypes during tissue repair
Novak, M. L., & Koh, T. J. (2013) · Journal of Leukocyte Biology · doi:10.1189/jlb.1012512 · Cited by 658 · cited 1×
“M1 macrophages produce pro-inflammatory cytokines and ROS, whereas M2 macrophages secret anti-inflammatory cytokines, accelerate inflammation resolution and promote tissue repair [42, 43], thus M2 macrophage was previously leveraged for UC therapy [22].”
BackgroundGao, C., Huang, Q., Liu, C., Kwong, C. H. T., Yue, L., Wan, J.-B., Lee, S. M. Y., & Wang, R. (2020) · Nature Communications · doi:10.1038/s41467-020-16439-7 · Cited by 630 · cited 2×
“Of a particular relevance, macrophage membrane coated NPs not only accumulated in the inflammatory sites specifically due to their inflammation-homing effects [18, 19], but also absorbed lipopolysaccharide (LPS) and inflammatory cytokines to regulate and suppress local inflammation in the management of sepsis [20], an…”
BackgroundMethodSelf-citationThamphiwatana, S., Angsantikul, P., Escajadillo, T., Zhang, Q., Olson, J., Luk, B. T., Zhang, S., Fang, R. H., Gao, W., Nizet, V., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1714267114 · Cited by 563 · cited 4×
“Of a particular relevance, macrophage membrane coated NPs not only accumulated in the inflammatory sites specifically due to their inflammation-homing effects [18, 19], but also absorbed lipopolysaccharide (LPS) and inflammatory cytokines to regulate and suppress local inflammation in the management of sepsis [20], an…”
BackgroundMethodInfluentialCell membrane-based nanoparticles: a new biomimetic platform for tumor diagnosis and treatment
Li, R., He, Y., Zhang, S., Qin, J., & Wang, J. (2018) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2017.11.009 · Cited by 430 · cited 1×
“Very recently, biomimetic drug delivery systems, particularly cell membrane coated NPs, have rapidly emerged and demonstrated improved treatment efficacy against cancer and inflammatory diseases [11-13], attributed to their highly biocompatible “self” nature and specific accumulation in targeted tissues and organs [14…”
BackgroundCyclodextrin‐Based Multistimuli‐Responsive Supramolecular Assemblies and Their Biological Functions
Zhang, Y., Liu, Y., & Liu, Y. (2020) · Advanced Materials · doi:10.1002/adma.201806158 · Cited by 400 · cited 1×
“, cyclodextrin-based nanoassemblies have exhibited significant potential in controlled drug delivery, attributed to their high biocompatibility and tunable functionality allowing responsiveness towards different stimuli [7].”
BackgroundRole of reactive metabolites of oxygen and nitrogen in inflammatory bowel disease
Pavlick, K. P., Laroux, F. S., Fuseler, J., Wolf, R. E., Gray, L., Hoffman, J., & Grisham, M. B. (2002) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(02)00853-5 · Cited by 373 · cited 2×
“For instance, by taking advantages of the elevated ROS level in ulcerative colon [8], the ROS-responsive nanoparticles (NPs) based on β-cyclodextrin derivatives firstly developed by Zhang and Li et al exhibited an excellent safety profile, improved drug accumulation in the inflammatory colon, and enhanced the therapeu…”
BackgroundMethodDiagnosis and classification of ulcerative colitis
Conrad, K., Roggenbuck, D., & Laass, M. W. (2014) · Autoimmunity Reviews · doi:10.1016/j.autrev.2014.01.028 · Cited by 368 · cited 1×
“The symptoms of UC, including diarrhea, weight loss, abdominal pain and rectal bleeding, significantly compromise the life quality of patients [2].”
BackgroundRed blood cell–derived nanoerythrosome for antigen delivery with enhanced cancer immunotherapy
Han, X., Shen, S., Fan, Q., Chen, G., Archibong, E., Dotti, G., Liu, Z., Gu, Z., & Wang, C. (2019) · Science Advances · doi:10.1126/sciadv.aaw6870 · Cited by 349 · cited 1×
“Gu and coworkers developed biomimetic nanomedince where the hybrid membranes from RBC and tumor cells functioned as tumor-antigen carriers and enhanced immunotherapy in combination with anti-programmed death ligand 1 (PD-L1) [17].”
BackgroundRoute to Rheumatoid Arthritis by Macrophage-Derived Microvesicle-Coated Nanoparticles
Li, R., He, Y., Zhu, Y., Jiang, L., Zhang, S., Qin, J., Wu, Q., Dai, W., Shen, S., Pang, Z., et al. (2019) · Nano Letters · doi:10.1021/acs.nanolett.8b03439 · Cited by 328 · cited 2×
“Of a particular relevance, macrophage membrane coated NPs not only accumulated in the inflammatory sites specifically due to their inflammation-homing effects [18, 19], but also absorbed lipopolysaccharide (LPS) and inflammatory cytokines to regulate and suppress local inflammation in the management of sepsis [20], an…”
BackgroundIn Vitro-Derived Alternatively Activated Macrophages Reduce Colonic Inflammation in Mice
Hunter, M. M., Wang, A., Parhar, K. S., Johnston, M. J. G., Van Rooijen, N., Beck, P. L., & McKay, D. M. (2010) · Gastroenterology · doi:10.1053/j.gastro.2009.12.041 · Cited by 311 · cited 3×
“M1 macrophages produce pro-inflammatory cytokines and ROS, whereas M2 macrophages secret anti-inflammatory cytokines, accelerate inflammation resolution and promote tissue repair [42, 43], thus M2 macrophage was previously leveraged for UC therapy [22].”
BackgroundMethodGou, S., Huang, Y., Wan, Y., Ma, Y., Zhou, X., Tong, X., Huang, J., Kang, Y., Pan, G., Dai, F., et al. (2019) · Biomaterials · doi:10.1016/j.biomaterials.2019.05.012 · Cited by 277 · cited 1×
“RMN were also relatively stable in PBS buffer (Figure S2B) [39].”
BackgroundCaterina, M., Patrizia, G., Valeria, C., Ornella, M., Arturo, L., & Vincenzo, Z. (1997) · The Journal of Nutrition · doi:10.1093/jn/127.2.286 · Cited by 271 · cited 2×
“Caco-2 cells were incubated in H2O2 (10 mM) containing media [33] and co-cultured with RLZ or RMN.”
MethodEngineering Cell Membrane‐Based Nanotherapeutics to Target Inflammation
Yan, H., Shao, D., Lao, Y., Li, M., Hu, H., & Leong, K. W. (2019) · Advanced Science · doi:10.1002/advs.201900605 · Cited by 240 · cited 3×
“Intravenous administration was adopted for protection of membrane proteins, which are essential for maintaining long systemic circulation, inflammatory tropism and sequestration of inflammatory cytokines [12].”
BackgroundNanozyme-mediated catalytic nanotherapy for inflammatory bowel disease
Zhao, J., Gao, W., Cai, X., Xu, J., Zou, D., Li, Z., Hu, B., & Zheng, Y. (2019) · Theranostics · doi:10.7150/thno.33727 · Cited by 239 · cited 1×
“Recently, many novel nanomedicines exhibited improved targeting efficiency and therapeutic effects in the treatment of UC [5, 6].”
BackgroundZhang, Q., Tao, H., Lin, Y., Hu, Y., An, H., Zhang, D., Feng, S., Hu, H., Wang, R., Li, X., et al. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2016.08.010 · Cited by 234 · cited 1×
“For instance, by taking advantages of the elevated ROS level in ulcerative colon [8], the ROS-responsive nanoparticles (NPs) based on β-cyclodextrin derivatives firstly developed by Zhang and Li et al exhibited an excellent safety profile, improved drug accumulation in the inflammatory colon, and enhanced the therapeu…”
BackgroundSelf-citationRosiglitazone for Active Ulcerative Colitis: A Randomized Placebo-Controlled Trial
Lewis, J. D., Lichtenstein, G. R., Deren, J. J., Sands, B. E., Hanauer, S. B., Katz, J. A., Lashner, B., Present, D. H., Chuai, S., Ellenberg, J. H., et al. (2008) · Gastroenterology · doi:10.1053/j.gastro.2007.12.012 · Cited by 229 · cited 1×
“Rosiglitazone, an agonist of peroxisome proliferator activated receptor γ (PPARγ) [23], was reported to induce M2 polarization of macrophages [24, 25], which contributed to its therapeutic effects against UC [26, 27].”
BackgroundLi, C., Zhao, Y., Cheng, J., Guo, J., Zhang, Q., Zhang, X., Ren, J., Wang, F., Huang, J., Hu, H., et al. (2019) · Advanced Science · doi:10.1002/advs.201900610 · Cited by 209 · cited 1×
“With the same ROSresponsive nanomedicine platform, pro-resolving peptide Ac2-26 was released in the high ROS environment specifically in the UC colon, driving inflammatory resolution effectively [10].”
BackgroundSelf-citationRole of Monocytes and Intestinal Macrophages in Crohnʼs Disease and Ulcerative Colitis
Gren, S. T., & Grip, O. (2016) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000824 · Cited by 180 · cited 1×
“As a part of immunological response, a large number of macrophages are recruited and accumulate in the ulcerative colon, resulting in sustained inflammation [40, 41].”
BackgroundZhu, W., Yu, J., Nie, Y., Shi, X., Liu, Y., Li, F., & Zhang, X.-L. (2014) · Immunological Investigations · doi:10.3109/08820139.2014.909456 · Cited by 171 · cited 1×
“In addition, increased M1 and decreased M2 macrophages are commonly observed in the inflammatory colon tissues of UC patients, and the disequilibrium between M1 and M2 correlates with the progression of UC [21].”
BackgroundSaubermann, L. J., Nakajima, A., Wada, K., Zhao, S., Terauchi, Y., Kadowaki, T., Aburatani, H., Matsuhashi, N., Nagai, R., & Blumberg, R. S. (2002) · Inflammatory Bowel Diseases · doi:10.1097/00054725-200209000-00004 · Cited by 164 · cited 1×
“All treatment groups were given the same amount of RLZ (10 mg/kg) [34] or blank NPs intravenously via tail vein on Day 0, 3 and 5 (three times totally) according to a modified literature treatment plan [35] with the first injection set on Day 0 (6 hours after the initial DSS treatment) to exploit the therapeutic poten…”
MethodMacrophage-based nanotherapeutic strategies in ulcerative colitis
Zhang, J., Zhao, Y., Hou, T., Zeng, H., Kalambhe, D., Wang, B., Shen, X., & Huang, Y. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.01.047 · Cited by 160 · cited 2×
“Recently, many novel nanomedicines exhibited improved targeting efficiency and therapeutic effects in the treatment of UC [5, 6].”
BackgroundSelf-citationZhang, D., Wei, Y., Chen, K., Zhang, X., Xu, X., Shi, Q., Han, S., Chen, X., Gong, H., Li, X., et al. (2014) · Advanced Healthcare Materials · doi:10.1002/adhm.201400299 · Cited by 158 · cited 3×
“The fabrication of Ox-CD NPs was based on the reported literature method [29].”
MethodResultSelf-citationNon-proinflammatory and responsive nanoplatforms for targeted treatment of atherosclerosis
Dou, Y., Chen, Y., Zhang, X., Xu, X., Chen, Y., Guo, J., Zhang, D., Wang, R., Li, X., & Zhang, J. (2017) · Biomaterials · doi:10.1016/j.biomaterials.2017.07.035 · Cited by 140 · cited 1×
“The synthesis of Ox-CD was performed according to a previously reported method [28].”
MethodSelf-citationHydrogen Peroxide Activates NF κ B and the Interleukin-6 Promoter Through NF κ B-Inducing Kinase
Zhang, J., Johnston, G., Stebler, B., & Keller, E. T. (2001) · Antioxidants & Redox Signaling · doi:10.1089/15230860152409121 · Cited by 125
Self-citationLi, M., Liu, Y., Chen, J., Liu, T., Gu, Z., Zhang, J., Gu, X., Teng, G., Yang, F., & Gu, N. (2018) · Theranostics · doi:10.7150/thno.27466 · Cited by 120 · cited 1×
“Very recently, biomimetic drug delivery systems, particularly cell membrane coated NPs, have rapidly emerged and demonstrated improved treatment efficacy against cancer and inflammatory diseases [11-13], attributed to their highly biocompatible “self” nature and specific accumulation in targeted tissues and organs [14…”
BackgroundSelf-citationWu, J., Lin, T., & Wu, K. K. (2009) · Journal of Cellular Physiology · doi:10.1002/jcp.21730 · Cited by 106 · cited 1×
“Mem all improved cell viability, implying the protective role of both membrane and RLZ against ROS induced cell damage, likely attributed to the anti-apoptotic effects of RLZ [44, 45].”
BackgroundYao, Q., Liu, J., Zhang, Z., Li, F., Zhang, C., Lai, B., Xiao, L., & Wang, N. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.003161 · Cited by 97
The PPARγ Agonist Rosiglitazone Impairs Colonic Inflammation in Mice with Experimental Colitis
Ramakers, J. D., Verstege, M. I., Thuijls, G., Te Velde, A. A., Mensink, R. P., & Plat, J. (2007) · Journal of Clinical Immunology · doi:10.1007/s10875-007-9074-2 · Cited by 95 · cited 1×
“Rosiglitazone, an agonist of peroxisome proliferator activated receptor γ (PPARγ) [23], was reported to induce M2 polarization of macrophages [24, 25], which contributed to its therapeutic effects against UC [26, 27].”
BackgroundNakao, N., Kurokawa, T., Nonami, T., Tumurkhuu, G., Koide, N., & Yokochi, T. (2008) · Innate Immunity · doi:10.1177/1753425908093932 · Cited by 69
A Biomimetic Gold Nanocages-Based Nanoplatform for Efficient Tumor Ablation and Reduced Inflammation
Xu, Q., Wan, J., Bie, N., Song, X., Yang, X., Yong, T., Zhao, Y., Yang, X., & Gan, L. (2018) · Theranostics · doi:10.7150/thno.27631 · Cited by 67 · cited 1×
“Very recently, biomimetic drug delivery systems, particularly cell membrane coated NPs, have rapidly emerged and demonstrated improved treatment efficacy against cancer and inflammatory diseases [11-13], attributed to their highly biocompatible “self” nature and specific accumulation in targeted tissues and organs [14…”
BackgroundHasegawa‐Moriyama, M., Ohnou, T., Godai, K., Kurimoto, T., Nakama, M., & Kanmura, Y. (2012) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2012.08.039 · Cited by 66
Garrity-Park, M. M., Loftus, E. V., Sandborn, W. J., & Smyrk, T. C. (2011) · Inflammatory Bowel Diseases · doi:10.1002/ibd.21681 · Cited by 65 · cited 1×
“Meanwhile, myeloperoxidase (MPO), a biomarker for neutrophil infiltration [52, 53], increased significantly in the inflammatory colon tissues of the colitis control mice (Figure 4C), indicating that a large number of neutrophils infiltrated into the colon.”
BackgroundStatus of colitis-associated cancer in ulcerative colitis
Kinugasa, T., & Akagi, Y. (2016) · World Journal of Gastrointestinal Oncology · doi:10.4251/wjgo.v8.i4.351 · Cited by 65 · cited 1×
“As the etiology is not clearly elucidated, the clinical treatments by pharmacotherapy nowadays are not very satisfactory, reflected by a high relapse rate and elevated risk of carcinogenesis [3, 4], mainly due to the poor specificity and inadequate suppression of Ivyspring”
BackgroundBiomarkers in the management of ulcerative colitis: a brief review
Masoodi, I., Tijjani, B. M., Wani, H. U., Hassan, N., Khan, A. B., & Hussain, S. (2011) · Europe PMC (PubMed Central) · doi:10.3205/000126 · Cited by 63 · cited 1×
“Meanwhile, myeloperoxidase (MPO), a biomarker for neutrophil infiltration [52, 53], increased significantly in the inflammatory colon tissues of the colitis control mice (Figure 4C), indicating that a large number of neutrophils infiltrated into the colon.”
BackgroundKepsutlu, B., Wycisk, V., Achazi, K., Kapishnikov, S., Perez-Berna, A. J., Guttmann, P., Cossmer, A., Pereiro, E., Ewers, H., Ballauff, M., et al. (2020) · ACS Nano · doi:10.1021/acsnano.9b09264 · Cited by 62 · cited 1×
“The internalization of free Cy5 and Cy5 loaded NPs was determined by flow cytometry in 4 hours and 24 hours, respectively according to the previous studies [30, 31] and the mean fluorescence intensity was statistically analyzed.”
MethodYang, F.-C., Chiu, P., Chen, Y., Mak, T. W., & Chen, N. (2019) · Journal of Biomedical Science · doi:10.1186/s12929-019-0539-4 · Cited by 56 · cited 1×
“Histology of the colon was graded with a scoring system according to the reference [37].”
MethodPotenza, M. A., Gagliardi, S., Benedictis, L. D., Zigrino, A., Tiravanti, E., Colantuono, G., Federici, A., Lorusso, L., Benagiano, V., Quon, M. J., et al. (2009) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00291.2009 · Cited by 47 · cited 1×
“Mem all improved cell viability, implying the protective role of both membrane and RLZ against ROS induced cell damage, likely attributed to the anti-apoptotic effects of RLZ [44, 45].”
BackgroundPark, J. S., Yi, T., Park, J., Han, Y. M., Kim, J., Shin, D.-H., Tak, S. J., Lee, K., Lee, Y. S., Jeon, M., et al. (2015) · Journal of Clinical Biochemistry and Nutrition · doi:10.3164/jcbn.15-56 · Cited by 43 · cited 1×
“All treatment groups were given the same amount of RLZ (10 mg/kg) [34] or blank NPs intravenously via tail vein on Day 0, 3 and 5 (three times totally) according to a modified literature treatment plan [35] with the first injection set on Day 0 (6 hours after the initial DSS treatment) to exploit the therapeutic poten…”
MethodLi, J., & Shen, X. (2019) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-019-0432-z · Cited by 42 · cited 1×
“All treatment groups were given the same amount of RLZ (10 mg/kg) [34] or blank NPs intravenously via tail vein on Day 0, 3 and 5 (three times totally) according to a modified literature treatment plan [35] with the first injection set on Day 0 (6 hours after the initial DSS treatment) to exploit the therapeutic poten…”
Method
Cited by
Wu, Y., Wan, S., Yang, S., Hu, H., Zhang, C., Lai, J., Zhou, J., Chen, W., Tang, X., Luo, J., et al. (2022) · Journal of Nanobiotechnology · doi:10.1186/s12951-022-01746-6 · Cited by 301
Current research trends of nanomedicines
Liu, Q., Zou, J., Chen, Z., He, W., & Wu, W. (2023) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2023.05.018 · Cited by 213
“The macrophage membrane guided the nanomedicine to the inflammatory colon and helped suppress inflammation by sequestering proinflammatory cytokines, exhibiting synergistic therapeutic effects against ulcerative colitis 363 .”
BackgroundZhang, C., Li, J., Xiao, M., Wang, D., Qu, Y., Zou, L., Zheng, C., & Zhang, J. (2022) · Chinese Chemical Letters · doi:10.1016/j.cclet.2022.03.110 · Cited by 156
Self-citation
Metadata
- Authors
- Sun, T., Kwong, C. H. T., Gao, C., Wei, J., Yue, L., Zhang, J., Ye, R. D., & Wang, R.
- Venue
- Theranostics
- Publisher
- Ivyspring International Publisher
- Published
- 2020
- Volume
- 10
- Issue
- 22
- Pages
- 10106-10119
- ISSN
- 1838-7640 (ISSN-L)
- OpenAlex
- W3082125279
- Cited by
- 159
- References
- 51
- FWCI
- 10.07
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.